<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:News="http://www.bing.com/news/search?q=generic&amp;format=rss"><channel><title>generic - BingNews</title><link>http://www.bing.com/news/search?q=generic&amp;format=rss</link><description>Search results</description><image><url>http://www.bing.com/rsslogo.gif</url><title>generic</title><link>http://www.bing.com/news/search?q=generic&amp;format=rss</link></image><copyright>Copyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>Generic single-dose flu antiviral gets FDA's blessing</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a360f4a13e140afb3e174a5e7dda29f&amp;url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2fgeneric-single-dose-flu-antiviral-gets-fdas-blessing%2far-AA265DfK&amp;c=10669341188251046340&amp;mkt=en-us</link><description>Studies have shown baloxavir to be a standout among antivirals commonly used for influenza ...</description><pubDate>Thu, 18 Jun 2026 21:00:00 GMT</pubDate><News:Source>MedPage Today on MSN</News:Source><News:Image>http://www.bing.com/th?id=ONUT.QaaZCWVpbUNdTxDPcs_gRg&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1600</News:ImageMaxWidth><News:ImageMaxHeight>900</News:ImageMaxHeight></item><item><title>FDA Approves First Single-Dose Generic Treatment for Influenza</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a360f4a13e140afb3e174a5e7dda29f&amp;url=https%3a%2f%2fmarkets.businessinsider.com%2fnews%2fstocks%2ffda-approves-first-single-dose-generic-treatment-for-influenza-1036259607&amp;c=6750882940066927110&amp;mkt=en-us</link><description>The U.S. Food and Drug Administration today approved the first generic of Xofluza (baloxavir marboxil) tablets, the first single-dose treatment for acute uncomplicated influenza and prophylaxis in ...</description><pubDate>Thu, 18 Jun 2026 06:20:00 GMT</pubDate><News:Source>Markets Insider</News:Source><News:Image>http://www.bing.com/th?id=ONUT.cFW86HWUKroUeGsfYGnCWg&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>125</News:ImageMaxWidth><News:ImageMaxHeight>150</News:ImageMaxHeight></item><item><title>FDA approves first generic of Roche's flu drug Xofluza</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a360f4a13e140afb3e174a5e7dda29f&amp;url=https%3a%2f%2fpharmaphorum.com%2fnews%2ffda-approves-first-generic-roches-flu-drug-xofluza&amp;c=16104298026810708532&amp;mkt=en-us</link><description>The first generic alternative to Roche's oral drug for influenza, Xofluza, has been approved by the FDA and should be available in time for this year's flu season. The Xofluza (baloxavir marboxil) ...</description><pubDate>Thu, 18 Jun 2026 09:47:00 GMT</pubDate><News:Source>pharmaphorum</News:Source><News:Image>http://www.bing.com/th?id=ONUT.ILD_whB83mZzh0Zye5lI3g&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1200</News:ImageMaxWidth><News:ImageMaxHeight>675</News:ImageMaxHeight></item><item><title>Generic Drugs Market size is projected to reach USD 594.99 billion by 2031, With growing at a CAGR of 5.0% | The Insight Partners</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a360f4a13e140afb3e174a5e7dda29f&amp;url=https%3a%2f%2ffinance.yahoo.com%2fnews%2fgeneric-drugs-market-size-projected-143100791.html&amp;c=471676403715964777&amp;mkt=en-us</link><description>US &amp; Canada, May 09, 2025 (GLOBE NEWSWIRE) -- According to a new comprehensive report from The Insight Partners, the global Generic Drugs Market is growing owing to patent expiry and loss of market ...</description><pubDate>Thu, 08 May 2025 17:00:00 GMT</pubDate><News:Source>Yahoo Finance</News:Source></item><item><title>FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a360f4a13e140afb3e174a5e7dda29f&amp;url=https%3a%2f%2fwww.pharmtech.com%2fview%2ffda-duloxetine-recall-highlights-generic-manufacturing-quality-gaps&amp;c=3209735570554689822&amp;mkt=en-us</link><description>A Class II recall was initiated for duloxetine lots after N-nitroso-duloxetine exceeded FDA intake limits, reflecting low acute clinical risk but regulatory nonconformance. Nitrosamine issues ...</description><pubDate>Wed, 17 Jun 2026 16:42:00 GMT</pubDate><News:Source>PharmTech</News:Source></item><item><title>7 Generic Items You Should Always Buy — And 8 You Shouldn’t</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a360f4a13e140afb3e174a5e7dda29f&amp;url=https%3a%2f%2fwww.nasdaq.com%2farticles%2f7-generic-items-you-should-always-buy-and-8-you-shouldnt&amp;c=2484488875519273272&amp;mkt=en-us</link><description>Whether you’re single or married, have a large or small family, finding ways to save money is always a good idea. And with so many generic options out there these days, it’s often tempting to just buy ...</description><pubDate>Sun, 29 Oct 2023 14:00:00 GMT</pubDate><News:Source>Nasdaq</News:Source></item><item><title>Generic Drugs: The Same, but Not</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a360f4a13e140afb3e174a5e7dda29f&amp;url=https%3a%2f%2fwww.theatlantic.com%2fhealth%2farchive%2f2015%2f03%2fgeneric-drugs-the-same-but-not%2f388592%2f&amp;c=8472648164191913713&amp;mkt=en-us</link><description>I have a migraine. My son has strep throat. A patient presents to my clinic with signs of pneumonia. These are all common enough occurrences. When I have a migraine, a good cup of coffee and a few ...</description><pubDate>Sun, 29 Mar 2015 16:59:00 GMT</pubDate><News:Source>The Atlantic</News:Source></item><item><title>Generic drugmakers gain key victory in ‘skinny label’ patent case</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a360f4a13e140afb3e174a5e7dda29f&amp;url=https%3a%2f%2fwww.biopharmadive.com%2fnews%2famarin-hikma-skinny-label-supreme-court-decision-vascepa%2f822108%2f&amp;c=17933088940695469586&amp;mkt=en-us</link><description>The Supreme Court ruled that a knockoff version of Amarin’s Vascepa didn’t infringe on patents — a decision with far-reaching implications for the availability of generics.</description><pubDate>Fri, 05 Jun 2026 09:11:00 GMT</pubDate><News:Source>BioPharma Dive</News:Source><News:Image>http://www.bing.com/th?id=ONUT.7EEbt3jGWRwXXQtUu5qeEg&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>653</News:ImageMaxWidth><News:ImageMaxHeight>435</News:ImageMaxHeight></item><item><title>Justice Jackson pens unanimous decision backed by SCOTUS conservatives</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a360f4a13e140afb3e174a5e7dda29f&amp;url=https%3a%2f%2fwww.msn.com%2fen-us%2fmoney%2fcompanies%2fjustice-jackson-pens-unanimous-decision-backed-by-scotus-conservatives%2far-AA24Qe75&amp;c=9223554767473319267&amp;mkt=en-us</link><description>The Supreme Court rules 9–0 in a case led by Justice Jackson, shaping how patent law applies to generic drug “skinny labels.” ...</description><pubDate>Thu, 04 Jun 2026 09:20:38 GMT</pubDate><News:Source>Newsweek on MSN</News:Source></item><item><title>FDA Approves First Generic Single-Dose Flu Treatment</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a360f4a13e140afb3e174a5e7dda29f&amp;url=https%3a%2f%2fwww.marketwatch.com%2fstory%2ffda-approves-first-generic-single-dose-flu-treatment-1be15676&amp;c=7498822959475321656&amp;mkt=en-us</link><description>The Food and Drug Administration approved the first generic version of Genentech's Xofluza, the first single-dose treatment for influenza, ahead of the 2026-2027 flu season.</description><pubDate>Thu, 18 Jun 2026 09:50:00 GMT</pubDate><News:Source>MarketWatch</News:Source></item></channel></rss>